Leoni Mollie's Form 4 filing
Kura Oncology, Inc. (KURA) · filed Jan 28, 2025
- Accession no.
- 0000950170-25-010121
- Filed
- Jan 28, 2025
- Trade date
- Jan 28, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $39.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leoni MollieCIK 0002051106 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2025 | Common Stock | SSaleDisposed | −2,253 | $7.87 | −$17,731.11 | 90,963 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −1,353 | $7.87 | −$10,648.11 | 89,610 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −816 | $7.87 | −$6,421.92 | 88,794 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −541 | $7.87 | −$4,257.67 | 88,253 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.